News

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is one of the best affordable biotech stocks to invest in now. Rigel ...
This biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. The ...
Innovative Pharmaceutical Biotech ( ($HK:0399) ) just unveiled an announcement. Innovative Pharmaceutical Biotech Limited has announced a further ...
As the Houston region positions itself to become a national hub for pharmaceutical manufacturing, San Jacinto College is ...
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is one of the best affordable biotech stocks to invest in now. On September 8, ...
Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition ...
A Boston biotech with an FDA-approved drug is laying off half of its staff just eight months after its last round of layoffs, ...
KARACHI: Ali & Associates, in collaboration with the US Consulate General Karachi, successfully hosted a high-level ...
Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...
Cash-strapped drug developer LB Pharmaceuticals said on Monday it was aiming for a valuation of up to $321.6 million in its New York initial public offering, potentially setting up the first sizable U ...
Funds from the US are flowing into biotech ETFs as investors seek unique opportunities to beat the market, China AMC’s Heidi Cai says.
The company with only 121 employees and no products, no revenue has overtaken industry heavyweights in just over 80 days. Read more at straitstimes.com. Read more at straitstimes.com.